Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN UROLOGY

June 2021

UROLOGY

CHALLENGING CASE REPORT: HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN THE RETREATMENT SETTING

By: Amy E. Krambeck, MD and Matthew Lee, MD
A 67-year-old man with a history of enlarged prostate and lower urinary tract symptoms was experiencing a weak stream and urinary frequency. His local urologist had initially treated him with Flomax (0.4 mg twice daily) and finasteride (5 mg daily), which he had been taking for two years.
 
His symptoms were somewhat controlled with medical management, but he developed urinary retention after he underwent elective laparoscopic gallbladder removal. He discussed surgical options with his local urologist and chose to proceed with UroliftÒ, which is a minimally invasive surgical treatment (MIST) that can be performed in the office and works by using surgical clips that mechanically retract prostate tissue open. The Urolift initially improved the patient’s symptoms, but after about one year, he developed worsening of his urinary frequency and urgency.
 
He was then referred to me for a second opinion. Many patients come to see me after previously undergoing MISTs such as Urolift or RezumÒ. Holmium laser enucleation of the prostate (HoLEP) is a surgical treatment for enlarged prostate that can be used for any prostate size and allows for maximum removal of excess prostate tissue. This means that the relief from HoLEP should be durable for the rest of the patient’s life, with no need for further medication or interventions.
 
HoLEP can be performed even if a man has undergone prior surgical treatment (including options such as Urolift, Rezum, microwave, TURP or Greenlight laser prostatectomy). For this patient, we discussed that because Urolift does not remove tissue, its benefits can be temporary, and some kind of prostate tissue removal is often required. We reassured this patient that his Urolift clips would be removed during the HoLEP. We discussed the risks and benefits of HoLEP as well as the alternatives. The patient agreed to proceed with surgery.
 
The HoLEP surgery went smoothly and all Urolift clips were removed during the operation. We observed him in the recovery area and confirmed there was minimal bleeding. His catheter was removed, and he was able to empty his bladder completely with a powerful stream. He was discharged the same day, only hours after his surgery. He was instructed to not exercise for one week after surgery. 
 
Today, the patient is extremely happy that he went through with the HoLEP surgery. He is voiding better than he has in decades, and his urinary frequency has decreased. He wishes he had gotten his HoLEP sooner. 

Listen to a recent Better Edge podcast featuring Dr. Krambeck on HoLEP >
Headshot of Dr. Amy E. Krambeck
Amy E. Krambeck, MD, professor of Urology at Northwestern Medicine. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 312.695.8146
Find an NM Urologist

You May Also Like

Headshots of Dr. Amy Krambeck

January 2021

UROLOGY
Holmium Laser Enucleation of the Prostate (HoLEP): Platinum Standard for BPH Therapy?
Video still of Dr. Edward Schaeffer

November 2020

UROLOGY
Investigating the Clinical and Molecular Biology of High-Risk Prostate Cancer
Video still of Dr. Ashley Ross

September 2020

UROLOGY
Genetic Testing for Prostate Cancer Management, Part 1

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties